Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Hilar Cholangiocarcinoma

gemcitabine has been researched along with Hilar Cholangiocarcinoma in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (8.00)29.6817
2010's12 (48.00)24.3611
2020's11 (44.00)2.80

Authors

AuthorsStudies
Fukushima, K; Hayashi, H; Hosoda, K; Kobayashi, R; Kubota, K; Motoyama, H; Notake, T; Shimizu, A; Soejima, Y; Sugenoya, S; Yasukawa, K1
Ebata, T; Mizuno, T; Takahashi, D1
Mungmungpuntipantip, R; Wiwanitkit, V1
Endo, I; Hiratani, S; Homma, Y; Kumamoto, T; Matsuyama, R; Miyake, K; Mori, R; Murakami, T; Ota, Y; Sawada, Y; Shimizu, Y; Yabusita, Y1
Arasawa, S; Fukunaga, T; Goda, K; Hoshi, S; Hoshi, T; Inamoto, O; Kajimura, K; Miyajima, S; Takaya, H; Takeda, S; Tanaka, Y1
Hwang, JH; Kim, J; Kim, MJ; Lee, JC; Lee, KH; Lee, WJ; Shin, DW; Woo, SM1
Hsiao, CY; Huang, KW; Li, X; Yang, PC1
Choi, SJ; Hwang, HW; Jeong, S; Lee, DH; Park, JS1
Belkouz, A; Erdmann, JI; Franken, LC; Klümpen, HJ; Nooijen, LE; Punt, CJA; Riady, H; van Oijen, MGH1
Anjarwalla, S; Lakshmaiah, S; Marzouk, O1
Ando, M; Ebata, T; Igami, T; Maeda, O; Mizuno, T; Onoe, S; Takahashi, D; Watanabe, N; Yamaguchi, J; Yokoyama, Y1
Brade, A; Dawson, LA; Gallinger, S; Greig, PD; Horgan, AM; Knox, JJ; Loveday, BPT; Metser, U; Moulton, CA1
Eskens, FALM; Groot Koerkamp, B; Heijmen, BJM; Koedijk, MS; Méndez Romero, A; Poley, JW; Sprengers, D; van der Holt, B; van der Laan, LJW; van Gent, DC; Willemssen, FEJA1
Akita, H; Asaoka, T; Doki, Y; Eguchi, H; Gotoh, K; Hatano, E; Higashiguchi, M; Ioka, T; Iwagami, Y; Kobayashi, S; Mori, M; Noda, T; Sakai, D; Yamada, D1
Autorino, R; Bisello, S; Brandi, G; Buwenge, M; Cammelli, S; Cellini, F; Cilla, S; Deodato, F; Macchia, G; Mattiucci, GC; Morganti, AG; Palloni, A; Tagliaferri, L; Valentini, V1
Diniz, AL; Forsmark, CE; Zhu, AX1
Augustyn, M; Grys, I; Iwaniec-Karlikowska, E1
Guan, J; Li, H; Tong, DN; Zhang, ZY; Zhou, GW; Zhou, ZQ1
Ebata, T; Igami, T; Mizuno, T; Nagino, M; Sugawara, G; Yamaguchi, J; Yokoyama, Y1
Bang, S; Cha, J; Kim, HM; Lee, KJ; Park, SW; Seong, J; Song, SY; Yi, SW1
Akita, H; Fujiwara, Y; Fukui, K; Gotoh, K; Kobayashi, S; Marubashi, S; Sakon, M; Takahashi, H; Teshima, T; Tomokuni, A; Yamada, T1
Fukumoto, K; Kobayashi, H; Koizumi, N; Nakase, Y; Takagi, T1
Ambrosino, G; Baiocchi, C; Costantin, G; Febbraro, A; Francescon, P; Guglielmi, R; Polistina, FA; Scalchi, P1
Alfieri, S; Cellini, N; Costamagna, G; Doglietto, GB; Luzi, S; Macchia, G; Morganti, AG; Smaniotto, D; Trodella, L; Valentini, V1
Berster, J; Beuers, U; Böck, S; Graeb, C; Heinemann, V; Jacobs, T; Kolligs, FT; Schäfer, C; Schirra, J; Schönberg, SO; Thasler, W; Wilkowski, R; Zech, CJ1

Reviews

2 review(s) available for gemcitabine and Hilar Cholangiocarcinoma

ArticleYear
Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review.
    Cancer treatment reviews, 2020, Volume: 91

    Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxycytidine; Female; Gemcitabine; Humans; Induction Chemotherapy; Klatskin Tumor; Male; Middle Aged; Treatment Outcome

2020
[Interdisciplinary diagnosis of and therapy for cholangiocarcinoma].
    Zeitschrift fur Gastroenterologie, 2008, Volume: 46, Issue:1

    Topics: Algorithms; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Deoxycytidine; Drainage; Endosonography; Gemcitabine; Hepatic Duct, Common; Humans; Klatskin Tumor; Liver Transplantation; Magnetic Resonance Imaging; Tomography, X-Ray Computed

2008

Trials

4 trial(s) available for gemcitabine and Hilar Cholangiocarcinoma

ArticleYear
Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma.
    Annals of surgical oncology, 2022, Volume: 29, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Deoxycytidine; Gemcitabine; Humans; Klatskin Tumor; Neoadjuvant Therapy; Pancreatic Neoplasms

2022
Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study.
    BMJ open, 2018, 10-15, Volume: 8, Issue:10

    Topics: Bile Duct Neoplasms; Cisplatin; Clinical Trials, Phase I as Topic; Combined Modality Therapy; Deoxycytidine; Feasibility Studies; Gemcitabine; Humans; Klatskin Tumor; Netherlands; Quality of Life; Radiosurgery; Treatment Outcome

2018
Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.
    Oncotarget, 2016, May-03, Volume: 7, Issue:18

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; CA-19-9 Antigen; Deoxycytidine; Disease-Free Survival; Drug Combinations; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Klatskin Tumor; Male; Middle Aged; Oxonic Acid; Tegafur

2016
Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I study.
    Onkologie, 2003, Volume: 26, Issue:4

    Topics: Aged; Bile Duct Neoplasms; Combined Modality Therapy; Common Bile Duct Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gallbladder Neoplasms; Gemcitabine; Hepatic Duct, Common; Humans; Infusions, Intravenous; Klatskin Tumor; Lymphatic Irradiation; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant

2003

Other Studies

19 other study(ies) available for gemcitabine and Hilar Cholangiocarcinoma

ArticleYear
Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer.
    Oncology, 2021, Volume: 99, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Surgical Procedures; Chemotherapy, Adjuvant; Common Bile Duct Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Combinations; Female; Follow-Up Studies; Gallbladder Neoplasms; Gemcitabine; Humans; Klatskin Tumor; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Propensity Score; Survival Rate; Tegafur

2021
Reply to comment on "Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma".
    Journal of hepato-biliary-pancreatic sciences, 2022, Volume: 29, Issue:4

    Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Deoxycytidine; Gemcitabine; Humans; Klatskin Tumor

2022
Comment on "Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma".
    Journal of hepato-biliary-pancreatic sciences, 2022, Volume: 29, Issue:4

    Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Deoxycytidine; Gemcitabine; Humans; Klatskin Tumor

2022
[Successful R0 Resection of Hilar Cholangiocarcinoma Invading the Inferior Vena Cava through Left Trisegmentectomy with Combined Resection of the Portal Vein and Inferior Vena Cava after Gemcitabine/Cisplatin Combination Chemotherapy-A Case Report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:4

    Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Female; Gemcitabine; Hepatectomy; Humans; Klatskin Tumor; Portal Vein; Vena Cava, Inferior

2022
Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study.
    American journal of clinical oncology, 2020, Volume: 43, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cisplatin; Deoxycytidine; Drainage; Female; Gemcitabine; Humans; Klatskin Tumor; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Time Factors

2020
Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma.
    Scientific reports, 2020, 07-02, Volume: 10, Issue:1

    Topics: Ablation Techniques; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts; Chemotherapy, Adjuvant; Combined Modality Therapy; Constriction, Pathologic; Deoxycytidine; Electroporation; Female; Follow-Up Studies; Gemcitabine; Humans; Klatskin Tumor; Laparotomy; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Treatment Outcome

2020
Klatskin tumor diagnosed concurrently with IgG4 related sclerosing cholangitis: A case report.
    Medicine, 2020, Aug-21, Volume: 99, Issue:34

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cisplatin; Common Bile Duct; Deoxycytidine; Diagnosis, Differential; Gemcitabine; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Jaundice; Klatskin Tumor; Male; Pruritus; Steroids; Tomography, X-Ray Computed; Treatment Outcome

2020
Perihilar clear cell cholangiocarcinoma: an often-diagnostic challenge.
    BMJ case reports, 2020, Dec-22, Volume: 13, Issue:12

    Topics: Adenocarcinoma, Clear Cell; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biopsy; Cholangiography; Cholangiopancreatography, Magnetic Resonance; Cisplatin; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Fatal Outcome; Gemcitabine; Hepatic Duct, Common; Humans; Klatskin Tumor; Male; Palliative Care; Positron Emission Tomography Computed Tomography

2020
Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma: A propensity score-adjusted analysis.
    Journal of hepato-biliary-pancreatic sciences, 2021, Volume: 28, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemotherapy, Adjuvant; Cholangiocarcinoma; Deoxycytidine; Gemcitabine; Humans; Klatskin Tumor; Propensity Score; Retrospective Studies

2021
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
    Journal of surgical oncology, 2018, Volume: 117, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Klatskin Tumor; Liver Transplantation; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Prospective Studies; Survival Rate

2018
[Successful R0 Resection of Hilar Cholangiocarcinoma by Extrahepatic Bile Duct Resection Due to Accompanying Liver Dysfunction after Neoadjuvant Gemcitabine/Cisplatin/S-1 Combination Chemotherapy-A Case Report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Gemcitabine; Humans; Klatskin Tumor; Male; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography

2019
Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
    Anticancer research, 2019, Volume: 39, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Brachytherapy; Chemoradiotherapy; Cholangiocarcinoma; Deoxycytidine; Dose Fractionation, Radiation; Female; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Klatskin Tumor; Male; Middle Aged; Neoplasm Staging; Progression-Free Survival; Retrospective Studies; Risk Factors; Time Factors

2019
Consensus conference on hilar cholangiocarcinoma.
    HPB : the official journal of the International Hepato Pancreato Biliary Association, 2015, Volume: 17, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biopsy; Cholangiopancreatography, Endoscopic Retrograde; Cisplatin; Deoxycytidine; Embolization, Therapeutic; Gemcitabine; Humans; Klatskin Tumor; Liver Transplantation; Magnetic Resonance Imaging; Neoplasm Staging; Portal Vein; Tomography, Spiral Computed; Treatment Outcome

2015
[Klatskin tumor - a case report].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2016, Volume: 40, Issue:236

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Klatskin Tumor; Male; Middle Aged; Remission Induction; Stents

2016
Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis.
    Surgery today, 2017, Volume: 47, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Biliary Tract Surgical Procedures; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Hepatectomy; Humans; Klatskin Tumor; Lymphatic Metastasis; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome

2017
A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer.
    Cancer chemotherapy and pharmacology, 2016, Volume: 78, Issue:4

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Chemoradiotherapy; Cholangiocarcinoma; Cisplatin; Combined Modality Therapy; Common Bile Duct Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Klatskin Tumor; Male; Middle Aged; Pilot Projects; Tomography, X-Ray Computed; Treatment Outcome

2016
A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2017, Volume: 43, Issue:4

    Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Biliary Tract Neoplasms; Chemoradiotherapy; Cholangiocarcinoma; Deoxycytidine; Disease-Free Survival; Female; Gallbladder Neoplasms; Gemcitabine; Hepatectomy; Humans; Klatskin Tumor; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pancreaticoduodenectomy; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed

2017
[A Case of Peritoneal Dissemination of Hilar Cholangiocarcinoma Presenting with Hematuria Six Years after Radical Surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cisplatin; Deoxycytidine; Gemcitabine; Hematuria; Humans; Klatskin Tumor; Male; Peritoneal Neoplasms; Time Factors

2016
Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2011, Volume: 99, Issue:2

    Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Chi-Square Distribution; Cholangiocarcinoma; Combined Modality Therapy; Contrast Media; Deoxycytidine; Dose Fractionation, Radiation; Female; Gemcitabine; Hepatic Duct, Common; Humans; Klatskin Tumor; Lymphatic Metastasis; Male; Middle Aged; Radiosurgery; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome

2011